Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cancer drug setback tarnishes AstraZeneca's R&D claims
Cancer drug setback tarnishes AstraZeneca's R&D claims
Cancer drug setback tarnishes AstraZeneca's R&D claims
Submitted by
admin
on June 26, 2014 - 9:34am
Source:
Yahoo/Reuters
News Tags:
AstraZeneca
R&D
ovarian cancer
olaparib
Headline:
Cancer drug setback tarnishes AstraZeneca's R&D claims
Do Not Allow Advertisers to Use My Personal information
